| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 316.936 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 318.987 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 357.303 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 279.804 | 87 |
| GSM780720 | Untreated after 4 days (C2_2) | 331.798 | 88 |
| GSM780721 | Untreated after 4 days (C3_2) | 285.186 | 87 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 386.654 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 272.714 | 87 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 292.934 | 87 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 334.154 | 88 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 257.121 | 86 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 306.068 | 88 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 239.354 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 296.064 | 87 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 276.643 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 233.426 | 85 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 257.544 | 86 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 272.533 | 87 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 270.451 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 260.972 | 86 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 335.837 | 88 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 256.948 | 86 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 302.986 | 87 |